title: [Subclinical hypothyroidism and cardiovascular risk factors].
abstract: OBJECTIVE
  To determine the prevalence of subclinical hypothyroidism in the general population of an urban health center and describe the clinical characteristics and cardiovascular risk factors in patients with subclinical hypothyroidism.
  
  
  METHODS
  An observational study, retrospective, reviewing the medical histories of patients sampled from June 2005 until July 2007. We analyzed the following variables; facts: age and sex. Family history thyroid disease and other diseases. Personal History: cardiovascular pulmonary autoimmune, alterations gynecology obstetric diabetes, hypertension (HT) dislipemia, obesity, psychiatric alterations and haematological. Laboratory data: novel TSH, free T4, antiperoxidase antibodies, total cholesterol and its fractions.
  
  
  RESULTS
  The prevalence of the sample of 100 patients collected over 8 months was 3.8% in the general population over 14 years, of which 79 were women and 21 were men. 13% were type 2 diabetics, 23% had HT and 40% had dyslipidemia. Overweight and obesity were present in 26%. The average level of TSH was 6.92 ± 2.29 μU/ml and the average level of free T4 was 1.16 ± 0.16 ng/ml.
  
  
  CONCLUSIONS
  Prevalence subclinical hypothyroidism was 3.8%. especially in women with a mean age of 46. The incidence of cardiovascular risk factors in the subjects studied is higher in DM (13%), similar to general population in terms of dyslipidemia (40%) and obesity (23%) and lowest in hypertension (23%). In our study we observed a common pattern in the management of subclinical hypothyroidism, requiring the implementation and promotion of practice guidelines in primary care.
authors.affiliation: Hospital Universitario de Albacete, Albacete, España.
authors.forename: Ma del C
authors.initials: Mdel C
authors.lastname: Frías López
authors.forename: P J
authors.initials: PJ
authors.lastname: Tárraga López
authors.forename: J A
authors.initials: JA
authors.lastname: Rodríguez Montes
authors.forename: J
authors.initials: J
authors.lastname: Solera Albero
authors.forename: A
authors.initials: A
authors.lastname: Celada Rodríguez
authors.forename: M A
authors.initials: MA
authors.lastname: López Cara
authors.forename: A
authors.initials: A
authors.lastname: Gálvez
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000150:complications* / Q000453:epidemiology; D002784:Cholesterol / Q000097:blood; D048909:Diabetes Complications / Q000453:epidemiology; D050171:Dyslipidemias / Q000453:epidemiology; D005190:Family; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000150:complications* / Q000453:epidemiology; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000453:epidemiology; D050177:Overweight / Q000150:complications / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D012737:Sex Factors; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D016896:Treatment Outcome
chemical_list: D013972:Thyrotropin; D002784:Cholesterol; D013974:Thyroxine